Patient Stories
It’s good to hear from people going through similar things as you. Listen to these stories and see if they sound like your own. Then click on “Share my Story” and you might just see yourself on CF Living one day, too.
Bridget K.
Stockton, CA
31 years old
Some days are easier than others. My inspiration comes from my family, friends and belief in myself. I try to remind myself that there are people in far more dire circumstances, that I should be grateful for what I do have.
CF doesn't define me, but it has necessitated the birth of a great strategy of how I approach the world. I believe it has made me more compassionate, aware of other points of view and flexible. When I can't meet all the goals I set for myself in exactly the way I'd like to, that's where the Plan B, C, D, etc. come into play. I call myself the "Queen of Plan B" because I always have back-up plans for when life throws an obstacle in my way.
Janine U.
Brooklyn, NY
52 years old
(median life expectancy for a person living with CF is 37)
I stay compliant because my life depends on it, and, in addition to doing the medications, these are the only bodies we have. If we don't take care of them, who will?
Theresa S.
Kennebunk, ME
44 years old
(median life expectancy for a person living with CF is 37)
I live one day at a time and believe that tomorrow always has something special in store for me.
I find inspiration in the incredible feats of other people. I believe that can accomplish my goals, no matter that I have CF.
-
Treatment Tip
Fitting in treatments can be hard. But it’s always time well spent. Click here for tips on fitting it all in.
Indication and Usage
Daily administration of Pulmozyme® (dornase alfa) Inhalation Solution along with standard therapies is indicated in the management of cystic fibrosis patients to improve lung function. In patients with a forced vital capacity (volume of air exhaled with maximum effort and speed) greater than or equal to 40% of predicted, daily administration of Pulmozyme has also been shown to reduce the risk of respiratory tract infections requiring the administration of injectable antibiotics. In our pivotal study, safety and efficacy of daily administration has not been studied in patients beyond 12 months.
Important Safety Information
Pulmozyme should not be used in patients who are allergic to any of its ingredients
Pulmozyme should be used along with standard therapies for cystic fibrosis
When starting Pulmozyme therapy, patients may experience change in or loss of their voice, discomfort in the throat, chest pain, red watery eyes, rash, dizziness, fever, or runny nose
These side effects are usually mild and short-lived
The effect of Pulmozyme on exercise tolerance has not been established in adults and children
For further information, please see the Pulmozyme full prescribing information. If you have questions, please discuss them with your CF healthcare team.
